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Clinical assessment of brain function relies heavily on indirect behavior-based tests.
Unfortunately, behavior-based assessments are subjective and therefore susceptible
to several confounding factors. Event-related brain potentials (ERPs), derived from
electroencephalography (EEG), are often used to provide objective, physiological
measures of brain function. Historically, ERPs have been characterized extensively within
research settings, with limited but growing clinical applications. Over the past 20 years,
we have developed clinical ERP applications for the evaluation of functional status
following serious injury and/or disease. This work has identified an important gap: the
need for a clinically accessible framework to evaluate ERP measures. Crucially, this
enables baseline measures before brain dysfunction occurs, andmight enable the routine
collection of brain function metrics in the future much like blood pressure measures
today. Here, we propose such a framework for extracting specific ERPs as potential
“brain vital signs.” This framework enabled the translation/transformation of complex ERP
data into accessible metrics of brain function for wider clinical utilization. To formalize the
framework, three essential ERPs were selected as initial indicators: (1) the auditory N100
(Auditory sensation); (2) the auditory oddball P300 (Basic attention); and (3) the auditory
speech processing N400 (Cognitive processing). First step validation was conducted on
healthy younger and older adults (age range: 22–82 years). Results confirmed specific
ERPs at the individual level (86.81–98.96%), verified predictable age-related differences
(P300 latency delays in older adults, p < 0.05), and demonstrated successful linear
transformation into the proposed brain vital sign (BVS) framework (basic attention latency
sub-component of BVS framework reflects delays in older adults, p < 0.05). The findings
represent an initial critical step in developing, extracting, and characterizing ERPs as
vital signs, critical for subsequent evaluation of dysfunction in conditions like concussion
and/or dementia.
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INTRODUCTION
Vital signs such as heart rate, pulse oxygenation, and blood
pressure are essential to monitoring and managing the health of
various body systems. Yet there are no such vital signs identified
for brain function—despite the clearly instrumental role such
vital signs could play. Current clinical assessments for screening
brain functional status relies largely on subjective, behavior-
based measures, such as the Glasgow Coma Scale (GCS), to
evaluate level of conscious awareness following brain injury
(Teasdale and Jennett, 1974, pp. 81–84; Reith et al., 2016, pp.
89–94). However, subjective behavior-based tests of this nature
have been reported to have misdiagnosis rates as high as 43%
(Gawryluk et al., 2010, p. 11; Schnakers et al., 2009, p. 35).
More detailed clinical evaluation of cognitive function and
associated impairments are often reliant on neuropsychological
assessment (Folstein et al., 1975, pp. 189–198; Lezak, 2004).
These too are behavior-based measures, depending heavily on
the patient’s capacity to produce voluntary, on-demand motor
and/or verbal responses to stimuli (Connolly and D’Arcy, 2000,
pp. 31–47). Unfortunately, confounding factors, such as motoric
and communicative limitations, often hamper greatly the clinical
effectiveness for many of these measures.
Over the last 20 years, our group has demonstrated the critical
need for a physiological, objective brain function assessment that
utilizes event-related potentials or ERPs (Connolly et al., 1995,
pp. 548–565; D’Arcy et al., 2003, pp. 662–672; Sculthorpe-Petley
et al., 2015, pp. 64–72). ERPs are derived from long-standing
electroencephalography (EEG; Pravdich-Neminsky, 1913, pp.
951–960). They can be recorded using minimal non-invasive
scalp electrodes, combined with time-locked stimulation, to
reflect target brain responses during information processing
(Gawryluk and D’Arcy, 2010; Gawryluk et al., 2010, p. 11). EEG
combines practical features of being accessible, available, low
cost, and portable (Giacino et al., 2014, pp. 99–114), which
makes the technology well suited for point-of-care applications
(Gawryluk et al., 2010, p. 11).Work to date has demonstrated that
ERPs can provide specific information across a spectrum of brain
functioning, from low-level sensory to higher level cognitive
processing (Luck, 2014). Moreover, ERPs have been shown to
have robust diagnostic and prognostic capabilities (Morlet et al.,
2000, pp. 198–206; D’Arcy et al., 2003, pp. 662–672; Kotchoubey
et al., 2005, pp. 2441–2453; Wijnen et al., 2007, pp. 597–605;
Vanhaudenhuyse et al., 2008, pp. 262–270; Daltrozzo et al., 2009,
pp. 53–62).
In recent years, clinical ERP integration has focused on
developing rapid, automated approaches in order to successfully
utilize key ERPs that can be robustly recorded at the individual-
level. The initial effort focused on developing a rapid evaluation
framework for neurological status after severe acquired brain
injuries, called the Halifax Consciousness Scanner (HCS; D’Arcy
et al., 2011, pp. 750–754). The HCS was developed to
examine the presence or absence of five key ERP responses
linked to sensation (N100), perception (mismatch negativity,
MMN), attention (P300), memory for one’s own name (early
negative enhancement, ENE), and semantic speech processing
(N400). These ERPs were validated across a large sample of
healthy individuals and clinically applied in neurological status
assessment (Sculthorpe-Petley et al., 2015, pp. 64–72; Fleck-
Prediger et al., 2014). However, it has become increasingly
clear that mere assessments of presence or absence of a
particular ERP does not fundamentally address the need to
measure healthy individual brain function over time. Effective
longitudinal monitoring of brain functional changes requires
the establishment of individual functional “baselines” of brain
vitality prior to conditions of dysfunction. Specifically, there is
no framework for establishing and monitoring well established
ERPs that can serve as indicators for an individual’s healthy brain
function, in spite of the evidence for relatively stable within-
subject variance over time (Williams et al., 2005, pp. 1605–1630;
Cassidy et al., 2012, pp. 659–664). This gap is essential to address
in order to successfully assess the significance of any ERP-related
change in which questions arise about possible dysfunction,
which are increasingly arising as a potential application and
common challenge in the evaluation of, for example, concussion
and/or dementia.
Accordingly, the objective of the current study was to begin
developing an initial framework to translate/transform ERPs
into practical and accessible brain vital signs. The conceptual
development of such a framework required a systematic process
anchored to other existing vital sign frameworks. Therefore, the
current paper is divided into two main sections: (1) a proposed
conceptual framework for brain vital signs; and (2) a first step
evaluation of practical implementation in a test sample of healthy
adults across the lifespan.
I. Brain vital sign framework: As with other vital signs,
a potential brain vital sign framework must satisfy some
fundamental requirements: (1) the responses should be EEG
hardware platform independent; (2) each response should be
extensively characterized within the literature; (3) responses
should be recorded reliably within healthy adult individuals1;
(4) they should be accessible to normative data comparisons for
essential response characteristics (e.g., amplitudes and latencies);
and (5) importantly, the responses should be translated
into a clinically accessible framework, which can be readily
communicated.
To start, we selected well-established sensation-to-cognition
ERPs2 : the N100, P300, and N4003 . A complex-to-basic
pyramidal approach provided an overview of the translation
from technical ERP nomenclature to easy to communicate brain
vital signs (Figure 1). Sub-scores reflective of specific brain
functions were derived from the mean and standard deviations
(Figure 2). Lastly, linearly transformed scores normalized to the
best possible results for each amplitude and latency measure were
created and referred to as elemental brain scores (EBS).
1Most ERP responses are also well characterized across brain development, but
require increasing reliance on age specific norms and caveats that are not discussed
here.
2While the main focus is on auditory ERP responses, all three are present across
both auditory and visual modalities.
3Note that the mismatch negativity (MMN; Duncan et al., 2009) may also be
considered a potential ERP response for a brain vital sign framework. As theMMN
can also be derived from the same auditory stimuli that elicit the N100/P300, it
remains possible candidate for future expansion.
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FIGURE 1 | Brain vital sign framework: (1) overall brain vital sign score:
highest 30; (2) ABC break down into Auditory sensation, Basic
attention, and Cognitive processing; and (3) Elemental Brain Scores
linearly transformed from N100, P300, and N400 response amplitudes
and latencies (3 responses*2 measures = 6 scores).
II. Practical implementation in healthy adults: To address
implementation, the following steps were undertaken: (1)
Hardware performance characterization was critical for
platform independence. While some studies have compared
hardware system performance for one time point analysis
(Ries et al., 2014, pp. 10–20), analysis of performance over
time was conducted to characterize instrument noise levels for
longitudinal monitoring. (2) Stimulus sequence optimization
was crucial to balance the trade-off between short testing times
and highest possible response signal-to-noise ratio (SNR). (3)
Response extraction and identification required an expert-
independent, quality-checked approach. (4) Response results
then required translation/transformation into the brain vital sign
framework for interpretation and reporting. (5) A test sample of
ERP data, with an age-related difference comparison embedded,
provided initial validation across the adult life span (i.e., younger
vs. older adults).
The current study utilized a healthy sample data set to test
three hypotheses: (1) The three ERPs would be detectable at
the individual level (Hypothesis 1); (2) Comparison between
younger and older adults will show predictable age-related
changes (Hypothesis 2); and (3) Because the brain vital sign
framework is generated by applying a linear transformation to
the raw ERP responses, we anticipate the pattern of age-related
ERP changes would be preserved in the EBS results. With this
initial step, it would then be possible to expand the brain vital sign
framework into more extensive normative development along
with applications in possible dysfunction related to conditions
like concussion and dementia.
METHODS
Characterizing and Calibration of EEG
Hardware Performance
Four candidate EEG systems (gNautilus and gMobiLab systems
manufactured by g.Tec Medical Engineering, and two Enobio
FIGURE 2 | ABC breakdown demonstrating graded measures.
Calculation shown for BVS sub-components “A”. Similar calculations
undertaken for “B” and “C”.
systemsmanufactured byNeuroelectrics) were evaluated in order
to identify the most reliable hardware. Hardware evaluation used
a 5-min known input calibration signal (“ground truth”), derived
from a combination of sinusoidal waves with frequencies of
5, 10, 15, and 30Hz (in MATLAB software). The test signal
was delivered through the audio output port (at maximum
volume setting) and recorded on 2 channels of the EEG systems
as well as a Tektronix oscilloscope (model # 795-TBS1052B).
Testing was conducted 2 times per day over 3 consecutive days
(6 total).
Stability and reliability was assessed using inter-channel
stability (correlation between channels at each time point of test),
day-over-day stability (percentage change in peak voltage over
the 3 days), peak-to-peak voltage recorded, and SNR (defined as
ratio of sum of spectral power surrounding the 5, 10, 15, 30Hz
[“signal”] and 60Hz [“noise”]). The g.Nautilus device, provided
maximal SNR and had the best recording stability over the 3 days
(average change 1.45% over 3 days, see Supplementary Material
for full results), and was therefore utilized for subsequent human
data collection.
Scalp-recorded ERPs were recorded from 3midline electrodes
(Fz, Cz, & Pz, embedded within a cap), insert earphones,
g.Nautilus EEG acquisition hardware (bandpass: dc-250Hz,
500Hz sampling, 3 axis head motion accelerometers), and a
portable computing platform. Four additional electrodes provide
ground (forehead), reference (ear lobe) and eye monitoring
(electro-oculogram, EOG).
Following signal amplification, conditioning, and digitization,
the data were transmitted over Bluetooth link to the
portable host computer. Time-stamping signals were sent
from the host computer using custom-designed USB-to-
TTL converter subsystem to mark stimulus presentation
events. These TTL pulses were logged by the amplifier along
with the EEG data and later used for signal averaging to
derive ERPs.
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Stimulus Sequence Balancing SNR and
Short Testing Time
Auditory tone and spoken word pair stimuli were presented
through the insert earphones. Tone stimuli elicited the N100
and P300 responses and spoken word pairs elicited the N400
(Figure 3). Tones (100ms duration) were divided into standard
(75 dB, 80%) and deviant (100 dB, 20%) conditions, with the
N100 and the P300 derived from the deviant condition. Paired
spoken words were divided into congruent prime pairs (e.g.,
bread-butter, 50%) and incongruent prime pairs (Romeo-table,
50%). The N400 was derived from the incongruent prime word
pairs. The interlacing of tones and word pair stimuli enabled
full optimization of near maximum trials per unit time (e.g., 5
s/stimulus cycle× 60 cycles= 5min).
ERP Response Elicitation, Extraction and
Identification
EEG scans were conducted with minimal preparation compared
to conventional EEG techniques (<5min setup). Each
participant was fitted with an elastic cap with embedded
electrodes, and g.GAMMAsys electrode gel was injected at
each location for conductivity. EOG channels were recorded
using disposable Ag/AgCl electrodes on the supra-orbital ridge
and outer canthus of the left eye. Skin-electrode impedances
were maintained at <30k impedance at each site. Acoustic
stimuli were delivered binaurally through Etymotic ER4 insert
earphones. Participants were instructed to pay attention to the
auditory stimuli while maintaining visual fixation on a cross
located 2.0m away (black on white background). Three runs of
the 5-min stimulus sequence were collected on each participant
(approximately 15min total run time).
Automated ERP pre-processing used established methods,
including spectral filtering, segmentation, baseline correction,
and conditional averaging (Luck, 2014). Signal-to-noise
optimizations include ocular correction to remove eye
artifact, jittered stimulus timing to minimize potential
alpha contamination, and artifact de-noising using pattern
recognition. ERP processing parameters were as follows: 1–20Hz
bandpass filter, 60Hz notch filter, −100–900ms epoch length
for segmentation relative to stimulus onset. ERP response
identification was undertaken through a template matching
process in which N100, P300, and N400 peaks were identified
FIGURE 3 | Schematic illustration of auditory stimulus sequence
consisting of words and tones.
by specifying expected polarity within expected temporal ranges
(Marchand et al., 2002, pp. 1715–1722). Each ERP response value
was measured as peak-to-peak measure relative to the preceding
peak of opposite polarity.
Machine learning methods such as support vector machine
(SVM), allow training of two-category classifiers to distinguish
contrasting experimental conditions (see Parvar et al., 2014, pp.
1–12; Sculthorpe-Petley et al., 2015, pp. 64–72). The best results
were obtained using single run, trial-averaged data from all three-
electrode sites as inputs to the SVM with a radial kernel. Ninety
Percent of the available data were randomly selected to train a
two-category classifier to distinguish between the two stimulus
conditions for each experiment (i.e., standard vs. deviant tones
for N100 & P300, congruent vs. incongruent words for N400).
The trained classifier was then applied to the remaining 10%
of datasets to test the accuracy of classification. Under 10-
fold cross-validation, this process is repeated 10 times such
that the classifier is trained and tested on all available data.
The total instances of correct group classification (ex. number
of correct standard and deviant classifications) relative to the
total number of classifications provide an accuracy number.
Standard statistical measures including true positive (TP), false
positive (FP), sensitivity, and specificity are derived from the
confusion matrix. The SVM analyses were further verified using
non-parametric permutation statistics to assess if the observed
performance could be obtained by chance ((Golland and Fischl,
2003), pp. 330–341). This involved randomly redistributing the
class labels in the training sets and observing the performance
of the new SVM solution. After 1000 permutations, the observed
classification accuracies were used as a null distribution against
which the significance of the true SVM solution was determined.
Translation/Transformation of ERP
Responses to Brain Vital Sign Framework
First, similar to neuropsychology assessment, a total brain vital
sign score of 30 was defined to represent the most basic result:
all responses fall with the normative range, bounded by standard
deviation. The highest level of brain vital sign framework
combines all three ERP peak amplitude (µV) and latency (ms)
measures, ranked in terms of standard deviations from the mean
(M/SDs), into one composite score of 30. The total brain vital
sign score of 30 reflects overall healthy brain processing4. The
total scores for each participant were generated by comparing
the amplitude (X) and latency (L) measures of each of the 3
components to the normative database, with scoring criteria
determined using the mean (µ) and standard deviation (σ) of the
corresponding measures in the normative database. Details are
shown in Table 1.
A standard clinical scheme of “ABC” was implemented for
the breakdown of individual responses, with the N100 as an
indicator for Auditory sensation (A) (Davis, 1939, pp. 494–
499); the P300 as an indicator for Basic attention (B) (Sutton
et al., 1967, pp. 1436–1439); and the N400 as an indicator for
Cognitive processing during speech perception (C) (Kutas and
4Note that the initial SD cut-off can be customized and optimized in accordance
with the enhanced development of normative databases.
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TABLE 1 | BVS scoring criteria for the three ERP components.
P300 N400 & N100
Amplitude (X)/ BVS Amplitude (X)/ BVS
Latency (L) Score Latency (L) Score
X > µ − σ 5 X < µ + σ 5
L < µ + σ L < µ + σ
µ − 1.5σ < X < µ − σ 4 µ + 1.5σ > X > µ + σ 4
µ + 1.5σ > L > µ + σ µ + 1.5σ > L > µ + σ
µ − 2σ < X < µ − 1.5σ 3 µ + 2σ > X > µ + 1.5σ 3
µ + 2σ > L > µ + 1.5σ µ + 2σ > L > µ + 1.5σ
µ − 2.5σ < X < µ − 2σ 2 µ + 2.5σ > X > µ + 2σ 2
µ + 2.5σ > L > µ + 2σ
µ + 2.5σ > L > µ + 2σ
X < µ − 2.5σ 1 X > µ + 2.5σ 1
L > µ + 2.5σ
L > µ + 2.5σ
Hillyard, 1980, pp. 203–205). Within the ABC scheme 5 points
for amplitude and latency each were awarded. In addition to
establishing a healthy brain vital sign range (A = 10, B =
10, C = 10; Total 30), it was also possible to derive metrics
for monitoring ABC amplitude and latency changes over time.
Amplitude and latency metrics for ABC were used to calculate
6 elemental brain scores (EBS). Each EBS was normalized to the
best possible response measurement. Therefore, for each EBS, it
is possible to rank ABC amplitude and latency results relative
to the largest normative ERP response amplitude and shortest
normative ERP response latency, with scores ranging from 0
to 1. A score of 1 matched the outer bounds for best possible
measurement.
Mathematically, EBS measures can be expressed as shown in
equations 1 and 2 below:








Where, M is the mean value of the amplitude/latency, max is
the maximum value and min is the minimum value and best is
the “ideal” value that should be achieved. Best value can either
be the max or the min value depending on whether the lowest
or the highest value represents the ideal situation—generally
for latency the lowest (smallest) value represents faster (better)
processing, whereas for amplitude the highest positive value or
lowest negative value is thought to represent ideal processing.
Equation (1) was utilized for N100 and N400 amplitude
and latency as well as P300 latency, whereas Equation (2) was
used for P300 amplitude. All EBS calculations were undertaken
using an existing database of 100 healthy controls (Sculthorpe-
Petley et al., 2015, pp. 64–72) containing information about
N100, P300 and N400 components. To account for outliers in
the normative database, all data values were ranked, and the
interquartile range between 75th and 25th percentiles calculated.
Extremity thresholds were determined by calculating the points
corresponding to 1.5-times the interquartile range above the 75th
percentile, and 1.5-times the interquartile range below the 25th
percentile. Data points beyond the boundary formed by these
thresholds were excluded as outliers from the normative database
prior to BVS and EBS extraction. This process resulted in the
removal of 6 participants (out of 100) from the N100 amplitude
database, 2 participants from the N100 latency database, 1
participant from the N400 amplitude, 6 participants from the
P300 amplitude database and 1 participant from the P300 latency
database. No participants were excluded from the N400 latency
database.
Initial Validation across the Healthy Adult
Lifespan
Sixteen (16) participants ranging in age from 22 to 82 years were
recruited (46.81 ± 22.14, 8 females). A bimodally distributed
sample was selected across lifespan, with 8 in the 20–35 year-
old range (26.13 ± 4.00, 4 females) and 8 in the 50–85
year-old range (67.5 ± 11.25, 4 females). Participants had no
history of neurological problems or psychoactive medications.
All individuals were fluent in English and had normal or
corrected-to-normal hearing. EEG noise compromised data from
2 participants. Furthermore, to ensure analyses used a minimum
of a 20-year age separation with controlled age-appropriate
cognitively matched samples, data from 2 participants were not
included (1 from each sub-sample). The final matched analysis
therefore included 6 in the 20–30 year range and 6 in the 50–85
year range. Research Ethics Boards at Simon Fraser University
and Fraser Health Authority approved the study.
Each participant underwent neuropsychological screening
along with EEG/ERP testing using Mini Mental State Exam
(MMSE) (Folstein et al., 1975, pp. 189–198) and Montreal
Cognitive Assessment (MoCA) (Nasreddine et al., 2005, pp.
695–699). MMSE examines 5 areas of cognition (orientation,
registration, attention and calculation, recall, and language), with
scores below 23 suggestive of cognitive impairment (maximum
score 30; Folstein et al., 1975, pp. 189–198). MoCA examines
a multitude of high-level cognitive functions (e.g., short-term
memory recall, delayed recall, visuospatial abilities, working
memory, and language etc.).
ERP results were divided into the two groups (20–30 and
50–85 age ranges). Quantitative group-level ERP response
characteristics were compared using two-tailed independent
samples t-test. Results are presented as mean ± SD. Moreover,
to assess the performance of the expert-independent method
(SVM) across the age ranges, a sub-analysis was undertaken
for each group to compare and contrast any performance
differences.
ERP responses were also transformed into the brain vital sign
framework, generating an overall brain vital sign score and the
6 EBS scores each participant. EBS scores were compared at the
group-level. Normality was assessed using the Shapiro-Wilk W
test. Only the EBS measures for amplitude in the “C” component
of the framework did not pass the normality test, and they were
therefore compared using the Wilcoxon test. All others were
compared using two-tailed independent-samples t-test. Results
are presented as mean± SD.
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RESULTS
Participant Cognitive Status Evaluation
Participant characteristics and MMSE/MoCA scores are
presented in Table 2. Both the younger (age 20–30) and older
(age 50–85) groups scored in the healthy range. All individuals in
the younger group obtained full scores (30/30) for both MMSE
and MoCA. Participants in the older group scored 30 for MMSE
and 29.3± 0.5 for MoCA.
ERP Response Extraction and
Expert-Independent Identification
Figure 4 shows the ERP components evoked using the stimulus
sequence in representative individuals for the 20–30 and 50–85
age ranges. The N100 component was elicited during Auditory
sensation (−6.74± 2.13 µV). The P300 was elicited during Basic
attention to deviant tones (10.72 ± 2.66µV). The N400 was
elicited during Cognitive processing of semantically incongruent
word pairs (−5.09 ± 2.67 µV). All components were present in
all participants. Figure 5 presents group-averaged ERP results.
ERP response results indicate that the trained SVM classifier
successfully identified predicted response differences. For the
P300, the SVM classification included deviant vs. standard tones.
The individual-level accuracy of P300 classification is 98.96%
across all ages, with 0.98 sensitivity and 1.00 specificity (Table 3).
For the N400, the SVM classification included incongruent
vs. congruent word pairs. The individual-level classification
accuracy for N400 is 86.81% across all ages, with 0.84 sensitivity
and 0.90 specificity (Table 3). Permutation analysis verified the
accuracy of the SVM classification for P300 (p < 0.001) andN400
(p = 0.05).
Translation to the Brain Vital Sign
Framework
The participant responses were successfully translated into the
brain vital sign framework. Relative to norms, the representative
TABLE 2 | Sample characteristics and cognitive test scores.
Age 20–30 Age 50–85
Sample Size (n) 6 6
Education (years) 18.3 ± 1.9 17.8 ± 5.6
MMSE (/30) 30 30
MoCA (/30) 30 29.3 ± 0.5
Sex (M:F) 1:1 1:2
TABLE 3 | SVM classification for P300 and N400.
P300 N400
Accuracy 98.96% 86.81%
True positive 0.98 0.84
False positive 0.00 0.10
Sensitivity 0.98 0.84
Specificity 1.00 0.90
participants in Figure 5 both scored full 30, allocated the
maximum 10 for each of the A, B, and C components. All
individuals achieved scores of 30. EBS scores were also calculated:
(A) amplitude (0.56 ± 0.17) and latency (0.41 ± 0.25) for the
N100 using N = 99 norms; (B) amplitude (0.59 ± 0.11) and
latency (0.59± 0.14) for the P300 using N = 100 norms; and (C)
amplitude (0.50 ± 0.24) and latency (0.36 ± 0.16) for the N400
using N = 100 norms. As anticipated, each of the EBS measures
straddled the 50th percentile mark (=0.5, representing average
performance) within the mean± 1 standard deviation segment.
Initial Validation Across the Healthy Adult
Lifespan
Table 3 presents quantitative group-level component ERP
response characteristics. Table 4 shows that P300 latencies
increased significantly between younger and older groups (p <
0.05), with a similar trend for the N400 latencies (p = 0.07).
Table 5 shows that SVM classification undertaken separately for
the younger and older age groups, showed comparable results
between the two groups. Figure 6 and Table 6 show group-level
EBS scores between younger and older groups. Similar to P300
latency measures, the corresponding EBS score (“B” latency)
demonstrated a significant group difference (p < 0.05) between
old and young. Additionally, the “C” latency EBS also showed a
trend (p = 0.07) for group differences, again in agreement with
the corresponding N400 latency trends.
DISCUSSION
The current study had two objectives: (1) to describe a conceptual
framework for brain vital signs, which can provide an objective
physiological evaluation of healthy baseline brain function; and
(2) to conduct an initial practical evaluation in a test sample
of healthy adults across the lifespan. The results demonstrated
TABLE 4 | Quantitative measures for group-level ERP characteristics.
Age 20–30 Age 50–85
P300 Amplitude (µV) 11.09 ± 3.39 10.36 ± 1.91
Latency (ms) 276.00 ± 20.59 310.00 ± 15.02*
N400 Amplitude (µV) 5.93 ± 3.60 4.51 ± 1.00
Latency (ms) 460.67 ± 65.11 516.67 ± 57.53
Mean ± SD. *p < 0.05 between groups.
TABLE 5 | SVM classification comparisons between the two age groups.
P300, Younger P300, Older N400, Younger N400, Older
Accuracy 99.31% 98.61% 86.11% 86.11%
TP 0.99 0.97 0.88 0.85
FP 0.00 0.00 0.15 0.13
Sensitivity 0.99 0.97 0.88 0.85
Specificity 1.00 1.00 0.85 0.88
TP, True Positive; FP, False Positive.
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FIGURE 4 | ERP waveforms for a representative participant in the younger (age 20–30, participant age = 30) and middle-aged/older (age 50–85,
participant age = 60) age ranges. Data were averaged across 3 runs.
FIGURE 5 | ERP waveforms for group averages in the younger (age 20–30) and middle-aged/older (age 50–85) age ranges.
TABLE 6 | EBS values for group-level characteristics.
Age 20-30 Age 50-85
N100 Amplitude 0.57± 0.22 0.55± 0.13
Latency 0.47± 0.29 0.34± 0.20
P300 Amplitude 0.62 ± 0.14 0.56 ± 0.07
Latency 0.69 ± 0.12 0.49 ± 0.09*
N400 Amplitude 0.55 ± 0.32 0.44 ± 0.13
Latency 0.43 ± 0.16 0.30 ± 0.14
Mean ± SD.*p < 0.05 between groups.
the successful detection of the three key ERPs at the individual
level (Hypothesis 1), confirmed the expected pattern of age-
related ERP changes (Hypothesis 2), and enabled the translation
of ERPs into the brain vital sign framework (Hypothesis 3).
Importantly, this provided the initial step toward a brain
vital sign approach that preserves and simplifies the essential
valuable ERP results, but enables practical, accessible “vital sign”
attributes.
Robust individual level detection of ERPs like the N100,
P300, and N400 has become possible through machine
learning advances (Parvar et al., 2014; Sculthorpe-Petley
et al., 2015). Indeed, even within the current small initial
validation sample, the ERPs were successfully detected for
individuals across the life span (Figures 4, 5). SVM-based
analysis allowed expert-independent validation with high
accuracy, sensitivity, and specificity. SVM-based methods are
generally considered extremely well suited for use in biomedical
data due to their ability to deal with sparse learning scenarios
(Yeo et al., 2009, pp. 115–124). Traditionally, SVM-based
techniques for ERP are restricted to within-subject training and
classification for brain machine interface applications (Parvar
et al., 2014, pp. 1–12). By contrast, in the current application
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FIGURE 6 | EBS for group-level comparison. Mean ± SD. *p < 0.05
across groups.
the SVM-based methods involved between-subject training and
classification, further demonstrating potential for robust clinical
applications. Moreover, permutation analysis based verification
of performance provides further confidence regarding the
robustness of these approaches.
As an initial validity check, predictable age-related changes
in ERPs were examined and verified within the brain vital sign
framework. To demonstrate the relative sensitivity differences
between subjective behavioral tests and objective physiological
measures, standard mental status assessments were compared
to that of the ERP results. Results from MMSE and MoCA
were both in the healthy range for the younger (age 20–30)
and older (age 50–85) groups. While the ERP results generally
matched this pattern, it was possible to show subtle age-
related P300 latency delays (p = 0.008) in older adults,
consistent with previous studies (Braverman and Blum, 2003,
pp. 124–139). A similar trend was observed for N400 latency
delays (p = 0.07). Thus, while both behavior and brain—
based testing showed intact cognitive status, only the ERP
evidence showed enhanced sensitivity to age-related changes in
healthy brain function. Future work will further characterize
standard factors in larger normative samples. These include
characterization of aging related confounds, effects of education
levels, impact of concurrent changes in other vital signs such as
heart rate and blood pressure, and correlations between specific
EBS components and traditional behavioral measures. Similarly,
planned future work will also explore the opportunity to include
both resting state as well as other stimulus-related brain response
measures (such as event related spectral perturbations) into the
BVS framework.
To translate ERP results into the brain vital sign framework,
we applied a linear transformation to reduce complexity and
create a standard clinical schematic of ABC: (A) N100 =
Auditory sensation; (B) P300 = Basic attention; and (C) N400 =
Cognitive processing (Figure 1). Brain vital sign scores were then
derived through comparison to the mean and standard deviation
of the normative data. All participants showed an overall brain
vital sign score of 30, derived from perfect 10-point ABC
sub-scores (Figure 2). This component provided a normative
evaluation for healthy brain function. As an initial development
and to retain applicability over a wide range of potential
dysfunction, all components were weighted equally in this
framework. Future work may create variations/improvements
that weigh the components differently for applications in specific
disorders.
To transform ERP results into measurements of individual
changes over time, the amplitude and latency measurements
for all three responses were converted into 6 elemental brain
scores (EBS: 3 responses × 2 measurements). Importantly, the
EBS transformation involved a normative comparison against
the best possible measurement, resulting in scores ranging from
0 to 1. During initial validation, EBS transformation preserved
the pattern of age-related changes, with significant change in the
“B” component latency (p = 0.004) and a similar trend in “C”
component latency (p = 0.07).
The justification for a brain vital sign framework is strongly
within the need for a practical and objective physiological
measure of healthy brain function, combined with the capability
for portable EEG/ERPs to meet the practical requirements
and utilize well-established neural responses (i.e., studied
extensively for 35–70 years). The challenge has related to
translating/transforming ERPs to begin addressing the clinical
requirements for vital signs.
Accordingly, the current study represents only an initial
development effort, with a number of steps and caveats
remaining: (1) the initial validation used a relatively small sample
size, with further validation work currently being conducted; (2)
the critical need for hardware platform independence remains to
be systematically examined in order to understand differences
between EEG acquisition systems; (3) the development of
standardized normative databases represents an on-going
improvement and refinement; (4) the continuing development
of analyses to characterize sensitivity, specificity, reliability, and
other standard metrics are needed; and (5) more comprehensive
evaluations anchored to standard vital sign developmental
approaches must also be conducted. Nonetheless, the ability
to move beyond the traditional and heavily expert-dependent
ERP research setting to a more clinically-oriented brain vital
sign framework allows for a systematic method of assessing
healthy brain function. The current study provides an initial
demonstration of the framework, but the small sample size
necessitates that the results should be further validated in a
larger sample. Furthermore, it should be noted that there are
several approaches available for eliciting the ERP components.
We have demonstrated one approach that we believe makes
the oddball discrimination task easier in order to maximize
applicability across age groups and brain functional status.
Establishing a baseline measurement approach for healthy
brain function is critical, particularly when questions of
dysfunction arise due to conditions such as concussion and
Frontiers in Neuroscience | www.frontiersin.org 8 May 2016 | Volume 10 | Article 211
Ghosh Hajra et al. Developing Brain Vital Signs Framework
dementia. This study represents the initial steps toward such an
approach.
CONCLUSION
Clinical evaluations of healthy brain functioning is moving
from indirect subjective behavior-based tests, to objective,
physiological measures of brain function, such as those derived
from ERPs. We have previously demonstrated the essential
role for clinical ERPs to evaluate functional status following
serious injury and/or disease. The current study addressed an
important gap: the need for a clinical-accessible brain vital sign
framework that utilizes well-established ERPs. As an initial step,
the framework was used to evaluate healthy brain function
across the life span. The findings confirmed the ERPs at the
individual level, verified predictable age-related differences, and
demonstrated successful linear transformation to create the brain
vital sign framework.
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